| HOME >> BIOLOGY >> TECHNOLOGY |
INDIANAPOLIS, May 18 /PRNewswire/ -- AIT Laboratories, which specializes in pain management, forensics, and clinical testing, is announcing that its newly created pharmaceutical testing division will be known as AIT Bioscience, LLC. Recently, AIT Laboratories announced that the division will be located at its Indianapolis, Ind. headquarters.
(Logo: http://www.newscom.com/cgi-bin/prnh/20090518/DE18644LOGO )
"AIT Bioscience will operate under the same quality principles that I founded AIT Laboratories on 19 years ago," said AIT Laboratories President and CEO Michael A. Evans, Ph.D. "We have some of the industry's most veteran scientists leading the new division, including Ronald Shoup, Ph.D., who brings more than 30 years of leadership, entrepreneurship and scientific expertise to AIT Bioscience." Prior to joining AIT, Dr. Shoup was chief scientific officer of Bioanalytical Systems, Inc. in West Lafayette, Ind.
"Bioanalytical testing is closely aligned with what AIT Laboratories already does in terms of processes and equipment. AIT Bioscience wants to take those resources and apply them to the pharmaceutical industry in ways other CROs only wish they could," Shoup explained. "Our talent and lack of legacy systems allow us to build an organization from the ground up that caters to the client's specific needs. The goal is to work as a partner with drug developers to coordinate activities throughout the testing process and provide access to data in real time as it's produced by our laboratory."
The decision to create AIT Bioscience was based on AIT's desire to improve upon the traditional CRO model. The new company will provide clients the capability to monitor sample activity from point of collection to the final report in a completely paperless environment that assures correctness from one step to the next. In
'/>"/>
| SOURCE AIT Laboratories Copyright©2009 PR Newswire. All rights reserved |